Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Imipenem, sold under the brand name Primaxin among others, is a synthetic β-lactam antibiotic belonging to the carbapenems chemical class, developed by Merck scientists Burton Christensen, William Leanza, and Kenneth Wildonger in the mid-1970s. Carbapenems are highly resistant to the β-lactamase enzymes produced by many multiple drug-resistant…
Applications, Medical uses & Overview
Explore the main themes, entities and connections around Imipenem. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
developed carbapenems gram-negative bacteria thienamycin intravenous produced thus use activity medical spectrum name primaxin others key β-lactam resistant many antibiotics
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Imipenem | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Imipenem | AHFS/Drugs.com | International Drug Names | 1.00 | infobox |
| Imipenem | ATC code | J01DH51 (WHO) | 1.00 | infobox |
| Imipenem | CAS Number | 64221-86-9 Y | 1.00 | infobox |
| Imipenem | ChEBI | CHEBI:51799 Y | 1.00 | infobox |
| Imipenem | ChEMBL | ChEMBL43708 Y | 1.00 | infobox |
| Imipenem | ChemSpider | 4445535 Y | 1.00 | infobox |
| Imipenem | CompTox Dashboard (EPA) | DTXSID2023143 | 1.00 | infobox |
| Imipenem | DrugBank | DB01598 Y | 1.00 | infobox |
| Imipenem | ECHA InfoCard | 100.058.831 | 1.00 | infobox |
| Imipenem | Elimination half-life | 38 minutes (children), 60 minutes (adults) | 1.00 | infobox |
| Imipenem | Excretion | Urine (70%) | 1.00 | infobox |
| Imipenem | Formula | C12H17N3O4S | 1.00 | infobox |
| Imipenem | KEGG | D04515 Y | 1.00 | infobox |
| Imipenem | Legal status | AU: S4 (Prescription only) | 1.00 | infobox |
| Imipenem | Legal status | CA: ℞-only | 1.00 | infobox |
| Imipenem | Legal status | UK: POM (Prescription only) | 1.00 | infobox |
| Imipenem | Legal status | US: ℞-only | 1.00 | infobox |
| Imipenem | License data | US DailyMed: Imipenem | 1.00 | infobox |
| Imipenem | MedlinePlus | a686013 | 1.00 | infobox |
| Imipenem | Metabolism | Kidney | 1.00 | infobox |
| Imipenem | Molar mass | 299.35 g·mol−1 | 1.00 | infobox |
| Imipenem | PDB ligand | IM2 (PDBe, RCSB PDB) | 1.00 | infobox |
| Imipenem | Pregnancy category | AU: B3 | 1.00 | infobox |
| Imipenem | Protein binding | 20% | 1.00 | infobox |
| Imipenem | PubChem CID | 104838 | 1.00 | infobox |
| Imipenem | Routes of administration | Intramuscular, intravenous | 1.00 | infobox |
| Imipenem | Trade names | Primaxin, others | 1.00 | infobox |
| Imipenem | UNII | Q20IM7HE75 | 1.00 | infobox |
| Imipenem | is a | therapeutic alternative on the World Health Organization's List of Essential Medicines | 0.90 | text |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.